Email Updates

You are here

AVAC in the News

  • Although a start date hasn’t been announced, the South African arm of the Indian drug company Cipla has confirmed that a generic version of the two-monthly HIV prevention injection, CAB-LA (short for long-acting cabotegravir), will be made at its plants in Benoni or Durban. Cabotegravir is an antiretroviral drug that blocks HIV from entering someone’s cells.

    May 9, 2023
  • In 2018, Mike Ferraro was living on the street and sharing needles with other people who injected drugs when he found out he was HIV-positive. “I thought it was a death sentence, where you have sores and you deteriorate,” he said. Ferraro learned of his HIV status through a University of Miami Miller School of Medicine initiative called IDEA Exchange, which sent doctors and medical students to the corner where he panhandled. He got tested and enrolled in the program, which also provides clean syringes, overdose reversal medications, and HIV prevention and treatment drugs.

    April 24, 2023
    KFF Health News
  • Activists and health-care providers are already seeing the chilling effects of Uganda's proposals to further criminalise homosexuality. Sara Jerving reports.

    April 21, 2023
    The Lancet
  • Payer trade groups have written Democrats chairing five key U.S. House and Senate committees stating their Affordable Care Act plans will most likely continue to offer many preventive health services at no cost to members while the U.S. Supreme Court weighs the challenge known as Braidwood vs. Becerra. Advocates aren’t sure they mean it or for how long. The plaintiffs in Braidwood, a federal case in Texas, are contesting the right of the government to require payers to cover the full cost of care meant to prevent certain illnesses or conditions.

    April 21, 2023
    Health Payer Specialist
  • The best way to treat the worldwide epidemic of human immunodeficiency virus (HIV) infection is to prevent people from being infected in the first place, and pre-exposure prophylaxis (PrEP) appears to be a successful way to accomplish prevention among people who acquire the infection through sexual activity.

    April 18, 2023
    Breaking Med
  • The words “gridlock in Congress” are used so often that it’s hard to believe there are still issues that are truly bipartisan. However, after many decades, there is one issue that continues to receive support from both sides of the aisle. The effort to end HIV and AIDS has been not only a uniting cause in Congress, but it has also, through the President’s Emergency Plan for AIDS Relief (PEPFAR), resulted in one of the best examples of US global health leadership in history.

    April 14, 2023
    Health Affairs
  • The Ugandan parliament recently passed a draconian anti-LGBTQ law. The Anti-Homosexuality Act, as it is formally known, is intended “to protect the traditional family,” as its introduction states. However, it needs to be signed by the country’s president, Yoweri Museveni―who has previously campaigned against homosexuality―to become law. The bill follows a similar attempt at outlawing the LGBTQI community in 2014. That law was signed by Museveni, who has been president since 1986.

    April 4, 2023
  • Allan Maleche, the head of the Kenya Legal and Ethical Issues Network on HIV/AIDS (KELIN), remembers what his country was like before the introduction of lifesaving HIV medications in the early 2000s. “This sounds like a sob story, but people were on their deathbeds, writing their last will and testament,” he says. “The moment ARVs [antiretroviral medications] came on board, we saw a lot of people bounce back and become vibrant, helping others to not become HIV positive and being active citizens of the world.”

    March 31, 2023
  • This week, Ugandan Parliamant took steps toward implementing an anti-gay policy change that would further criminalize and endanger the lives of LGBTQIA+ people. AVAC condemns the proposed legislation and stands in solidarity with the LGBTQIA+ community in Uganda who face threats to their lives, draconian prison terms, and even the prospect of death sentences if this legislation goes forward.

    March 24, 2023
  • Researchers quickly recognized the potential of the long-term HIV prevention injectable. One of the key studies on the efficacy of the drug — which is a form of PrEP, used to prevent HIV infections — finished months ahead of schedule, as initial results showed the superiority of the injectable to a daily oral version of PrEP. CAB-LA only requires people to receive injections eight weeks apart after an introductory period.

    March 1, 2023